Does BOTULINUM TOXIN TYPE A Cause Hepatic cirrhosis? 72 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Hepatic cirrhosis have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 1.9% of all adverse event reports for BOTULINUM TOXIN TYPE A.
72
Reports of Hepatic cirrhosis with BOTULINUM TOXIN TYPE A
1.9%
of all BOTULINUM TOXIN TYPE A reports
72
Deaths
72
Hospitalizations
How Dangerous Is Hepatic cirrhosis From BOTULINUM TOXIN TYPE A?
Of the 72 reports, 72 (100.0%) resulted in death, 72 (100.0%) required hospitalization, and 72 (100.0%) were considered life-threatening.
Is Hepatic cirrhosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Hepatic cirrhosis?
ADALIMUMAB (1,760)
METHOTREXATE (1,650)
ETANERCEPT (931)
TOCILIZUMAB (903)
RITUXIMAB (863)
INFLIXIMAB (831)
ABATACEPT (824)
HYDROXYCHLOROQUINE (807)
LEFLUNOMIDE (780)
SULFASALAZINE (760)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Hepatic cirrhosis Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE